HLA Genes, Islet Autoantibodies, and Diabetic Retinopathy Risk
Author Information
Author(s): Richard A. Jensen, Elisabet Agardh, Åke Lernmark, Soffia Gudbjörnsdottir, Nicholas L. Smith, David S. Siscovick, Carina Törn
Primary Institution: University of Washington
Hypothesis
HLA genes, islet autoantibodies, and residual C-peptide are associated with the risk of diabetic retinopathy 15 years after the clinical onset of type 1 diabetes.
Conclusion
Increased levels of GADA at the onset of type 1 diabetes were associated with diabetic retinopathy 15 years later.
Supporting Evidence
- The prevalence of diabetic retinopathy was found to be 60.2% in the study population.
- GADA levels at diabetes onset were associated with increased risk of diabetic retinopathy 15 years later.
- The study adjusted for various confounding factors including duration of diabetes and HbA1c levels.
Takeaway
This study found that higher levels of a specific antibody (GADA) when diabetes starts can lead to a higher chance of eye problems later on.
Methodology
The study analyzed blood samples from participants diagnosed with type 1 diabetes to assess HLA genotype, islet autoantibodies, and C-peptide levels, followed by a review of fundus photographs for diabetic retinopathy.
Potential Biases
Participants with more severe diabetic retinopathy may have been less likely to participate in the study.
Limitations
The study only had current HbA1c levels, which may not reflect long-term blood glucose control, and the cohort was limited to individuals aged 15-34 at diagnosis.
Participant Demographics
Participants were aged 15-34 at diagnosis, with a majority being male (55%).
Statistical Information
P-Value
p=0.05
Confidence Interval
[95% CI 1.02 to 1.23]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website